Company Filing History:
Years Active: 1992-1998
Title: Joshua E Scharff: Innovator in Immunotoxin Research
Introduction
Joshua E Scharff is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of immunotoxins, particularly in the treatment of autoimmune diseases and T cell leukemias. With a total of 2 patents, Scharff's work is recognized for its innovative approaches to complex medical challenges.
Latest Patents
Scharff's latest patents include groundbreaking inventions such as "Immunotoxin with in vivo T cell suppressant activity and methods of use." This invention provides a method for treating autoimmune diseases in animals by administering an antibody-CRM9 conjugate that routes through the anti-CD3 pathway. Additionally, it offers a method for treating T cell leukemias or lymphomas using the same conjugate. Another significant patent is focused on an immunotoxin that relates to treating T cell leukemias, lymphomas, graft-versus-host diseases, and autoimmune diseases through the administration of an immunotoxin.
Career Highlights
Joshua E Scharff is associated with the United States of America as represented by the Department of Health. His work has been pivotal in advancing therapeutic methods that target specific immune responses, showcasing his commitment to improving health outcomes.
Collaborations
Scharff collaborates with David M Neville, contributing to the innovative research and development of immunotoxins. Their partnership exemplifies the collaborative spirit in scientific research, aimed at addressing critical health issues.
Conclusion
Joshua E Scharff stands out as an influential inventor in the field of immunotoxin research. His patents reflect a dedication to advancing medical treatments for serious conditions, making a lasting impact on the healthcare landscape.